Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Will Herbalife Earnings Be The Final Straw For Short Sellers?

Published 07/27/2014, 01:02 AM
Updated 07/09/2023, 06:31 AM
HLF
-

Herbalife Ltd. (NYSE:HLF) is set to report FQ2 2014 earnings after the market closes on Monday, July 28th. Herbalife is a multi-level marketing company which sells nutrition, weight management, and skin-care products. Herbalife was famously targeted by ostentatious hedge fund manager, Bill Ackman, in a $1 billion bet against the company in December of 2012.

Last week Bill Ackman went on CNBC and announced that he would be making the most important presentation of his career. Ackman claimed to have evidence that would strike a ‘deathblow’ to Herbalife and prove once and for it all that the company was an illegal pyramid scheme which targets poor latinos. Shares of HLF came tumbling down 10% after Ackman boldly made the announcement. Unfortunately for his fund, Pershing Square Capital Management, Mr. Ackman had much more bark than bite. He failed to prove anything definitively, and Herbalife stock made its highest single day percent gain in company history.

Ackman has made claims that Herbalife’s business model is unsustainable, but earnings and revenue both keep growing and growing. Here’s what investors are expecting from Herbalife on Monday.

Herbalife

This quarter 19 contributing analysts on Estimize.com have come to a consensus earnings expectation of $1.58 EPS and $1.365B in revenue compared to a consensus of $1.57 EPS and $1.363B from Wall Street. Over the previous 6 quarters the Estimize community has been more accurate than Wall Street in forecasting Herbalife’s earnings every time and has been more accurate on revenue 4 times.

EPS & Revenue

Herbalife has crushed both the Estimize and Wall Street consensus in 4 of the past 5 quarters. This quarter international expansion is believed to be fueling another huge quarter for Herbalife. Bears will hope that the media attention caused by the pyramid scheme allegations will keep consumers away from Herbalife products.

Herbalife Rankings

Estimize.com ranks and allows the sorting of analysts by accuracy, the analyst with the lowest error rate on Herbalife is an information technology professional who goes by the username pedroos. Over 2 previously scored estimates on Herbalife pedroos has averaged an error rate of 1.2%. Pedross has scored more than 4,100 points for his accuracy and is ranked 33rd overall among over 4,700 contributing analysts. Estimize is completely open and free for anyone to contribute, and the base of contributing analysts on the platform includes hedge fund analysts, asset managers, independent research shops, non professional investors, and students.

The Estimize consensus was more accurate than the Wall Street consensus 65% of the time last quarter on the coverage of nearly 1000 stocks. A combination of algorithms ensures that the data is not only clean and free from people attempting to game the system, but also weighs past performance and many other factors to gauge future accuracy.

EPS & Revenue

Contributing analysts on the Estimize.com platform are forecasting that on Monday Herbalife will report earnings 1c (

Original post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.